Ad is loading...
GNNSF
Price
$1.39
Change
-$0.00 (-0.00%)
Updated
Nov 8 closing price
PRLD
Price
$1.04
Change
+$0.01 (+0.97%)
Updated
Nov 15 closing price
114 days until earnings call
Ad is loading...

GNNSF vs PRLD

Header iconGNNSF vs PRLD Comparison
Open Charts GNNSF vs PRLDBanner chart's image
Genscript Biotech
Price$1.39
Change-$0.00 (-0.00%)
Volume$2K
CapitalizationN/A
Prelude Therapeutics
Price$1.04
Change+$0.01 (+0.97%)
Volume$426.13K
CapitalizationN/A
GNNSF vs PRLD Comparison Chart
Loading...
PRLD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GNNSF vs. PRLD commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNNSF is a Buy and PRLD is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (GNNSF: $1.39 vs. PRLD: $1.04)
Brand notoriety: GNNSF and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNNSF: 32% vs. PRLD: 110%
Market capitalization -- GNNSF: $3.15B vs. PRLD: $57.24M
GNNSF [@Biotechnology] is valued at $3.15B. PRLD’s [@Biotechnology] market capitalization is $57.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNNSF’s FA Score shows that 0 FA rating(s) are green whilePRLD’s FA Score has 1 green FA rating(s).

  • GNNSF’s FA Score: 0 green, 5 red.
  • PRLD’s FA Score: 1 green, 4 red.
According to our system of comparison, PRLD is a better buy in the long-term than GNNSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRLD’s TA Score shows that 3 TA indicator(s) are bullish.

  • PRLD’s TA Score: 3 bullish, 4 bearish.

Price Growth

GNNSF (@Biotechnology) experienced а 0.00% price change this week, while PRLD (@Biotechnology) price change was -12.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

PRLD is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNNSF($3.15B) has a higher market cap than PRLD($57.2M). GNNSF YTD gains are higher at: -43.033 vs. PRLD (-75.644). PRLD has higher annual earnings (EBITDA): -140.78M vs. GNNSF (-203.82M). GNNSF has more cash in the bank: 1.87B vs. PRLD (180M). PRLD has less debt than GNNSF: PRLD (18.2M) vs GNNSF (448M). GNNSF has higher revenues than PRLD: GNNSF (1.01B) vs PRLD (0).
GNNSFPRLDGNNSF / PRLD
Capitalization3.15B57.2M5,500%
EBITDA-203.82M-140.78M145%
Gain YTD-43.033-75.64457%
P/E RatioN/AN/A-
Revenue1.01B0-
Total Cash1.87B180M1,041%
Total Debt448M18.2M2,462%
FUNDAMENTALS RATINGS
GNNSF: Fundamental Ratings
GNNSF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
58
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRLD
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
75%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
PRLD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DEO118.16-1.69
-1.41%
Diageo plc
EXPI13.31-0.25
-1.84%
eXp World Holdings
BOOM8.02-0.21
-2.55%
DMC Global
QLYS145.52-3.87
-2.59%
Qualys
UONEK1.00-0.05
-4.76%
Urban One

GNNSF and

Correlation & Price change

A.I.dvisor tells us that GNNSF and ORYZF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNNSF and ORYZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNNSF
1D Price
Change %
GNNSF100%
N/A
ORYZF - GNNSF
24%
Poorly correlated
N/A
ARGNF - GNNSF
23%
Poorly correlated
N/A
CLDI - GNNSF
23%
Poorly correlated
+8.96%
PRLD - GNNSF
20%
Poorly correlated
+0.97%
HNSBF - GNNSF
17%
Poorly correlated
N/A
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with AMRN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
+0.97%
AMRN - PRLD
35%
Loosely correlated
-3.85%
AXON - PRLD
35%
Loosely correlated
-0.86%
ATNM - PRLD
32%
Poorly correlated
-9.09%
ABOS - PRLD
31%
Poorly correlated
-8.05%
GLYC - PRLD
31%
Poorly correlated
+4.16%
More